Skip to content

The Effectiveness of Augmented Reality to Enhance CPAP Therapy in OSA Patients

Using Augmented Reality to Establish and Evaluate the Effectiveness of a Set of Continuous Positive Airway Pressure Care Management Protocol for Obstructive Sleep Apnea Patients

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06520592
Acronym
CPAP OSA
Enrollment
60
Registered
2024-07-25
Start date
2025-06-20
Completion date
2026-07-31
Last updated
2025-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aherence, Mental Health, Physical Symptoms, Quality of Life

Keywords

Augmented Reality (AR), continuous positive airway pressure (CPAP), Adherence, Symptoms change

Brief summary

The goal of this clinical trial is to exam if artificial reality works to improve continuous positive airway pressure (CPAP) adherence in obstructive sleep apnea (OSA) patients. It will also learn about the feasibility of AR guided CPAP therapy. The main questions it aims to answer are: Does AR guided CPAP therapy increase the adherence of CPAP therapy among OSA patients? What barriers do participants have when using AR guided CPAP therapy? Researchers will compare AR guided CPAP therapy to a control (standard of care) to see if AR guided CPAP therapy works to enhance the adherence of CPAP therapy. Participants will: 1. Take AR guided CPAP therapy or standard of care every day for 6 months 2. Visit the clinic on baseline (t0), receiving CPAP therapy at the 1st month (t1), for checkups and tests, receiving CPAP therapy at the 3rd month (t2), receiving CPAP therapy at the 6th month (t3). 3. Response their symptoms on each following time.

Detailed description

Participants will randomly assign to two group, for experimental group will be received AR guided CPAP therapy. In the control group will be received standard of care.

Interventions

BEHAVIORALWith AR guided CPAP therapy

Participants will received AR training course to utilize the AR guided CPAP therapy

Sponsors

National Cheng-Kung University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Participnants will be randomly assigned to experimental or control groups by using block randomized method. In the study, we will use independent staff members who are not involved in outcome assessment to handle administrative tasks related to group assignments. In order to mask outcomes assessors, we will ensure that all documents and data sets used by the outcome assessors do not contain any information that could reveal group allocation.

Intervention model description

For the interventional group, they will utilize AR-guided CPAP therapy to ensure a proper fit of the CPAP device mask and successful adherence to the CPAP therapy. For the standard of care group, they will receive the standard of care.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* (1) Diagnosed with moderate to severe obstructive sleep apnea (AHI≥15) through polysomnography (PSG). * (2) Age is equal to or greater than 20 years old or equal.

Exclusion criteria

* (1) individuals who have previously used positive pressure ventilators for treatment, * (2) those diagnosed with central sleep apnea, * (3) those with uncontrolled acute mental illness, * (4) terminally ill patients.

Design outcomes

Primary

MeasureTime frameDescription
The adherence of CPAP therapyFrom enrollment to the end of treatment at 6 monthsAdherence refers to the patient's adherence to CPAP therapy, which means using CPAP for more than 70% of the total sleep time during the night, with a minimum duration of 4 hours. The calculation method involves dividing the number of days with CPAP use exceeding 4 hours by the total number of days and multiplying by 100 to obtain the average percentage of CPAP usage.

Countries

Taiwan

Contacts

Primary ContactYen Chin Chen, PhD
yenchin2427@gmail.com886-7-5252000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026